Showing 571-580 of 2392 results for "".
Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31314/Persistent Cognitive Deficits Post-Motor Vehicle Accident: A Case Study and Insights on Malingering in Neurological PracticeA 35-year-old male, Mr. M., presented five months after sustaining a whiplash injury from a motor vehicle accident. Initially treated by his chiropractor, Dr. J., Mr. M. contin
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31065/Recent studies highlighted in Practical Neurology’s January 2008 issue provide significant insights into neurological conditions and their broader health implications. Notably, research published in Neurology reveals that patients with Restless Legs Syndrome (RLS) face double the risk of stroke and
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31229/Recent developments in vascular disease management and neurology highlight both challenges and advancements crucial for healthcare professionals. The FDA, in collaboration with Baxter, issued a warning regarding delayed onset heparin-induced thrombocytopenia (HIT) and thrombosis (HITT) associated wi
Meningeal Enhancement Seen on Workup for Memory Loss
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/meningeal-enhancement-seen-on-workup-for-memory-loss/30222/Inflammation in the context of memory loss reminds us of the importance of checking opening pressure on lumbar puncture.Relapsing and Progressive Multiple Sclerosis: Understanding the Differences
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapsing-and-progressive-multiple-sclerosis-understanding-the-differences/30761/Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.Update on Refractory Status Epilepticus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/update-on-refractory-status-epilepticus/30758/The first priority for the consulting neurologist is confirming the diagnosis. Treating any underlying disease does far more to improve outcome than mere suppression of seizures. Treatment options exist for prolonged SE, but clinicians must be realistic with families.